Diagnostic value of non-coding RNAs in ovarian cancer

References

• Anastasiadou, E., Jacob, L. S. and Slack, F. J., 2018. Non-coding RNA networks in cancer. Nature Reviews Cancer, 18 (1), 5–18.
   PubMed Web of Science ®Google Scholar
• Braga, E. A., et al., 2020. LncRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms, International Journal of Molecular Sciences, 21 (22), 8855.
   Google Scholar
• Braicu, O. L., et al., 2017. miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples. OncoTargets and Therapy, 10, 4225–4238.
   PubMed Web of Science ®Google Scholar
• Chen, Y., et al., 2019. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer. Journal of Cellular Biochemistry, 120 (9), 14444–14454.
   PubMed Web of Science ®Google Scholar
• Chen, Y., et al., 2016. Human epididymis protein 4 expression positively correlated with miR-21 and served as a prognostic indicator in ovarian cancer. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, 37 (6), 8359–8365.
   PubMed Web of Science ®Google Scholar
• Dahiya, N., et al., 2008. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One, 3 (6), e2436.
   PubMed Web of Science ®Google Scholar
• Deb, B., Uddin, A. and Chakraborty, S., 2018. miRNAs and ovarian cancer: An overview. Journal of Cellular Physiology. 233, 3846–3854.
   PubMed Web of Science ®Google Scholar
• Dong, L., et al., 2020. A positive feedback loop of lncRNA DSCR8/miR-98-5p/STAT3/HIF-1α plays a role in the progression of ovarian cancer. Frontiers in Oncology, 10, 1713.
   PubMed Web of Science ®Google Scholar
• Dou, Q., et al., 2019. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein. European Journal of Pharmacology., 852, 134–141.
   PubMed Web of Science ®Google Scholar
• Gunel, T., et al., 2019. Regulation of HMGA2 and KRAS genes in epithelial ovarian cancer by miRNA has-let-7d-3p. Journal of Cancer Research and Therapeutics, 15 (6), 1321–1327.
   PubMed Web of Science ®Google Scholar
• Hao, B. and Zhang, J., 2019. miRNA-21 inhibition suppresses the human epithelial ovarian cancer by targeting PTEN signal pathway. Saudi Journal of Biological Sciences, 26 (8), 2026–2029.
   PubMed Web of Science ®Google Scholar
• Hemberg, M., et al., 2012. Integrated genome analysis suggests that most conserved non-coding sequences are regulatory factor binding sites. Nucleic Acids Research, 40 (16), 7858–7869.
   PubMed Web of Science ®Google Scholar
• Hu, J., et al., 2018a. The circular RNA circ-ITCH suppresses ovarian carcinoma progression through targeting miR-145/RASA1 signaling. Biochemical and Biophysical Research Communications, 505 (1), 222–228.
   PubMed Web of Science ®Google Scholar
• Hu, X., et al., 2018b. Competing endogenous RNA expression profiling in pre-eclampsia identifihashsa_circ_0036877 as a potential novel blood biomarker for early pre-eclampsia. Clinical Epigenetics. 10, 48.
   PubMed Web of Science ®Google Scholar
• Kobayashi, M., et al., 2014. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200. Journal of Translational Medicine, 12, 4.
   PubMed Web of Science ®Google Scholar
• Li, A. H. and Zhang, H. H., 2017. Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer. European Review for Medical and Pharmacological Sciences, 21 (24), 5618–5623.
   PubMed Web of Science ®Google Scholar
• Li, H., et al., 2017. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer. Biomedicine & Pharmacotherapy., 88, 529–534.
   PubMed Web of Science ®Google Scholar
• Li, J., et al., 2019a. Interaction between LncRNA-ROR and miR-145 contributes to epithelial-mesenchymal transition of ovarian cancer cells. General Physiology and Biophysics, 38 (6), 461–471.
   PubMed Web of Science ®Google Scholar
• Li, N., Zhan, X. and Zhan, X., 2018. The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes. Gynecologic Oncology, 150 (2), 343–354.
   PubMed Web of Science ®Google Scholar
• Li, Z., et al., 2019b. lncRNA UCA1 mediates resistance to cisplatin by regulating the miR-143/FOSL2-signaling pathway in ovarian cancer. Molecular Therapy. Nucleic Acids, 17, 92–101.
   PubMedGoogle Scholar
• Lin, X., et al., 2019. LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR-145. Molecular Carcinogenesis, 58 (12), 2286–2296.
   PubMed Web of Science ®Google Scholar
• Liu, C. N. and Zhang, H. Y., 2020. Serum lncRNA LOXL1-AS1 is a diagnostic and prognostic marker for epithelial ovarian cancer. The Journal of Gene Medicine, 22 (10), e3233.
   PubMed Web of Science ®Google Scholar
• Liu, H. Y., et al., 2019. miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT. European Review for Medical and Pharmacological Sciences, 23 (10), 4149–4155.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al., 2020. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway. Molecular Medicine Reports, 22 (5), 3667–3676.
   PubMed Web of Science ®Google Scholar
• Liu, R., et al., 2017. Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients. Scientific Reports, 7 (1), 18.
   PubMed Web of Science ®Google Scholar
• Liu, S., et al., 2018. Overexpression of the lncRNA FER1L4 inhibits paclitaxel tolerance of ovarian cancer cells via the regulation of the MAPK signaling pathway.
   Google Scholar
• Miao, J. T., et al., 2019. LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis. Bioscience Reports, 39 (7), BSR20182101.
   Google Scholar
• Oliveira, D. N. P., et al., 2019. Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass. PLoS One. 14, e0225249.
   PubMed Web of Science ®Google Scholar
• Ou, Y., et al., 2019. The expression profile of circRNA and its potential regulatory targets in the placentas of severe pre-eclampsia. Taiwanese Journal of Obstetrics & Gynecology, 58 (6), 769–777.
   PubMed Web of Science ®Google Scholar
• Pei, C., et al., 2020. CihasNA hsa_circ_0013958 may contribute to the development of ovarian cancer by affecting epithelial-mesenchymal transition and apoptotic signaling pathways. Journal of Clinical Laboratory Analysis, 34 (7), e23292.
   PubMed Web of Science ®Google Scholar
• Siegel, R. L. and Miller, K. D., 2020. Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7–30.
   PubMed Web of Science ®Google Scholar
• Tao, L. M., et al., 2020. LINC00662 promotes glycolysis and cell survival by regulating miR- 375/HIF-1α axis in ovarian cancer. Journal of Biological Regulators and Homeostatic Agents, 34 (3), 467–477.
   PubMed Web of Science ®Google Scholar
• Tung, S. L., et al., 2017. miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway. Oncogenesis, 6 (5), e326.
   PubMed Web of Science ®Google Scholar
• Wang, J., et al., 2019a. An integrated analysis reveals the oncogenic function of lncRNA LINC00511 in human ovarian cancer. Cancer Medicine, 8, 3026–3035.
   Google Scholar
• Wang, Y., et al., 2019b. Long noncoding RNA CDKN2B-AS1 interacts with miR-411-3p to regulate ovarian cancer in vitro and in vivo through HIF-1a/VEGF/P38 pathway. Biochemical and Biophysical Research Communications, 514 (1), 44–50.
   PubMed Web of Science ®Google Scholar
• Wu, M., et al., 2020. Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets. PeerJ., 8, e8961.
   PubMed Web of Science ®Google Scholar
• Xu, W. X., et al., 2019. MiR-145: a potential biomarker of cancer migration and invasion. American Journal of Translational Research, 11 (11), 6739–6753.
   PubMed Web of Science ®Google Scholar
• Xu, X., et al., 2017. Increased expression of LncRNA BANCR and its prognostic significance in human epithelial ovarian cancer. European Journal of Gynaecological Oncology, 38 (3), 449–452.
   PubMed Web of Science ®Google Scholar
• Yan, H., et al., 2020. Circular RNA-ITCH Inhibits the Proliferation of Ovarian Carcinoma by Downregulating lncRNA HULC. Reproductive Sciences (Thousand Oaks, Calif.), 27 (1), 375–379.
   PubMed Web of Science ®Google Scholar
• Yang, N., Zhang, Q. and Bi, X. J., 2020. MiRNA-96 accelerates the malignant progression of ovarian cancer via targeting FOXO3a. European Review for Medical and Pharmacological Sciences, 24 (1), 65–73.
   PubMed Web of Science ®Google Scholar
• Yu, X., et al., 2017. miRNA-21 enhances chemoresistance to cisplatin in epithelial ovarian cancer by negatively regulating PTEN. Oncology Letters, 14 (2), 1807–1810.
   PubMed Web of Science ®Google Scholar
• Zeng, S., et al., 2019a. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo. Cancer Biomarkers: section A of Disease Markers, 24 (4), 421–428.
   PubMed Web of Science ®Google Scholar
• Zeng, X. Y., et al., 2019b. lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2. Cancer Medicine, 8, 7074–7085.
   Google Scholar
• Zhang, M., et al., 2019. LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells. Cancer Biotherapy & Radiopharmaceuticals, 34 (5), 316–324.
   PubMed Web of Science ®Google Scholar
• Zhang, Y. G., et al., 2016. Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre-eclampsia. BJOG: An International Journal of Obstetrics and Gynaecology, 123 (13), 2113–2118.
   PubMed Web of Science ®Google Scholar
• Zhao, T., Du, J. and Zeng, H., 2020. Interplay between endoplasmic reticulum stress and non-coding RNAs in cancer. Journal of Hematology & Oncology 13, 163.
   PubMed Web of Science ®Google Scholar
• Zong, Z. H., et al., 2019. CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182. Journal of Experimental & Clinical Cancer Research: CR, 38 (1), 437.
   PubMed Web of Science ®Google Scholar